Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Am J Trop Med Hyg ; 104(3): 928-933, 2020 12 29.
Artículo en Inglés | MEDLINE | ID: mdl-33377447

RESUMEN

Leishmaniasis is endemic in the Indian subcontinent with predominance of visceral leishmaniasis (VL) due to Leishmania donovani. Cutaneous leishmaniasis (CL) is uncommon, and mucocutaneous leishmaniasis (MCL) is rarely reported in this region. Recent reports reveal a changing epidemiology and atypical manifestations. A retrospective study of 52 suspected cases with cutaneous and mucosal involvement seen from January 2008 to December 2018 in a tertiary care setting in a non-endemic state in southern India is reported. Twelve patients were confirmed to have leishmaniasis; seven had MCL, two had CL, and three had post-kala-azar dermal leishmaniasis (PKDL). All cases were male, with a median age of 41.5 years (interquartile range, 30-55.5 years), and the median duration of the disease was 6 years (interquartile range, 1-9.5 years). Patients with MCL had mucosal involvement including destructive ulcero-proliferative lesions due to delayed diagnosis; none had a history of travel to countries endemic for MCL and all were attributable to L. donovani species. On the other hand, Leishmania major which was the causative species in both CL patients was associated with travel to the Middle East. Patients with PKDL presented with multiple plaques and hypopigmented patches; one had concomitant VL and all were from endemic areas. Hitherto uncommon MCL, caused by potentially atypical variants of L. donovani, has emerged as a new manifestation of leishmaniasis in this region. A high index of suspicion based on lesions seen and history of travel combined with PCR-based diagnostics are required to confirm diagnosis for the various skin manifestations of leishmaniasis.


Asunto(s)
Leishmaniasis Cutánea/epidemiología , Leishmaniasis Cutánea/patología , Leishmaniasis Mucocutánea/epidemiología , Leishmaniasis Mucocutánea/patología , Piel/patología , Adolescente , Adulto , Anfotericina B/uso terapéutico , Antifúngicos/uso terapéutico , Gluconato de Sodio Antimonio/uso terapéutico , Antiprotozoarios/uso terapéutico , Ácido Desoxicólico/uso terapéutico , Combinación de Medicamentos , Humanos , India/epidemiología , Itraconazol/uso terapéutico , Leishmania donovani , Leishmania major , Leishmaniasis Cutánea/parasitología , Leishmaniasis Mucocutánea/parasitología , Masculino , Persona de Mediana Edad
2.
Indian J Dermatol ; 61(2): 236, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27057048

RESUMEN

We present a case of a 47-year-old man with 4 months history of conical growth on the prepuce with a progressive increase in size. The patient had been treated for seminoma a decade ago. Histopathology of the growth showed features of angiokeratoma. It is unusual for angiokeratoma to masquerade as a cutaneous horn.

3.
4.
Indian J Dermatol ; 61(1): 121, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26951737

RESUMEN

We report a case of a 42-year-old male who presented with second episode of bullous eruptions after ingestion of paracetamol. There were no systemic complaints. The temporal correlation with the drug, history of a similar episode and the quick improvement led us to a diagnosis of bullous fixed drug due to paracetamol. Applying Naranjo's algorithm, a causality score of 8 was obtained and was categorized as probable reaction to paracetamol. Clinicians should be vigilant of the possible adverse reactions to drugs with robust safety profiles. Drug alert cards could play an important role in preventing recurrences.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...